Table 1. Selected characteristics of facilities participating in the Provence Alpes Côte d’Azur Surveillance Epidemiologic System, France, July 1, 2013–March 20, 2016*.

Facility	Status	Geographic area	No. laboratories, N = 210	Wks since launch	Continuous or discontinuous	Start date of surveillance
LABM Labazur Provence	Private	Bouches-du-Rhône, Var, Vaucluse	26	142	Continuous	2013 Jul 1
LABM Alphabio	Private	Marseille	17	142	Continuous	2013 Jul 1
Clinique La Casamance	Public	Marseille	1	139	Continuous	2013 Jul 22
LABM Analys	Private	Boûches-du-Rhône	19	127	Discontinuous	2013 Oct 14
CH Aix-en-Provence	Public	Aix-en-Provence	1	122	Discontinuous	2013 Nov 18
CHU Nice	Public	Nice	1	118	Continuous	2013 Dec 16
CH Martigues	Public	Martigues	1	114	Continuous	2014 Jan 13
CH Salon-de-Provence	Public	Salon-de-Provence	1	109	Discontinuous	2014 Feb 14
Hôpital Inter-Armées, Laveran	Public	Marseille	1	100	Discontinuous	2014 Apr 21
LABM Cerba	Private	PACA	70	63	Continuous	2015 Jan 5
Hôpital Saint-Joseph	Public	Marseille	1	59	Discontinuous	2015 Feb 3
LABM BioAlliance	Private	Marseille	21	42	Continuous	2015 Jun 1
LABM Labazur Nice	Private	Alpes Maritimes	28	23	Continuous	2015 Oct 12
CH Dignes	Public	Dignes	1	11	Discontinuous	2016 Jan 1
LABM Barla	Private	Nice	21	7	Continuous	2016 Feb 3

*CH, Centre Hospitalier (Central Hospital); CHU, Centre Hospitalier Universitaire (Central University Hospital); LABM, Laboratoire de Biologie Médicale (Medical Laboratory); PACA, Provence Alpes Côte d’Azur.